<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, I believe we should develop Human monoclonal antibodies starting from PBMCs from convalescent people. These can be extremely important for therapy and prevention. In the case of Ebola, they were the fastest therapeutic tool to be developed.</p>
